MAZE THERAPEUTICS Trademark

Trademark Overview

On Tuesday, October 2, 2018, a trademark application was filed for MAZE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MAZE THERAPEUTICS trademark a serial number of 88140219. The federal status of this trademark filing is REGISTERED as of Tuesday, June 30, 2020. This trademark is owned by Maze Therapeutics, Inc.. The MAZE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development services; research in the field of genetic modifier therapeutics
maze therapeutics

General Information

Serial Number88140219
Word MarkMAZE THERAPEUTICS
Filing DateTuesday, October 2, 2018
Status700 - REGISTERED
Status DateTuesday, June 30, 2020
Registration Number6091697
Registration DateTuesday, June 30, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2019

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development services; research in the field of genetic modifier therapeutics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 10, 2018
Primary Code042
First Use Anywhere DateWednesday, October 31, 2018
First Use In Commerce DateWednesday, October 31, 2018

Trademark Owner History

Party NameMaze Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94080
Party NameMaze Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94080
Party NameMaze Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94158

Trademark Events

Event DateEvent Description
Wednesday, October 10, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 5, 2018NEW APPLICATION ENTERED
Tuesday, January 15, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, February 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 5, 2019PUBLISHED FOR OPPOSITION
Tuesday, March 5, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, January 14, 2019ASSIGNED TO EXAMINER
Tuesday, January 15, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 15, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, January 15, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 30, 2019ASSIGNED TO LIE
Tuesday, April 30, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 15, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 15, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 30, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, October 30, 2019SOU EXTENSION 1 FILED
Wednesday, October 30, 2019SOU EXTENSION 1 GRANTED
Wednesday, April 29, 2020TEAS STATEMENT OF USE RECEIVED
Friday, November 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 29, 2020USE AMENDMENT FILED
Wednesday, May 13, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 13, 2020STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 28, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 30, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, May 20, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 20, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 20, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 20, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 27, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 20, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 30, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

therapeutics maze research modifier genetic services development pharmaceutical field